Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2025

Innovation in actionable genomic alterations (AGA)

ALK Fusions: Where do we go after lorlatinib?

Date

26 Mar 2025

Session

Innovation in actionable genomic alterations (AGA)

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Geoffrey Liu

Authors

G. Liu

Author affiliations

  • UHN - University Health Network - Princess Margaret Cancer Center, Toronto/CA

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.